Overview

A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

Status:
Terminated
Trial end date:
2016-11-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the analgesic efficacy, safety, and tolerability of VM902A twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
Purdue Pharma LP
Treatments:
Analgesics
Naproxen